Maddie Hosick is originally from Kansas City, Missouri. She received her Bachelor of Science in Biology from Birmingham-Southern College and Doctor of Pharmacy degree from the University of Missouri-Kansas City in 2025. She completed her PGY-1 at University Health- Truman Medical Center. Her practice interests include oncology and pain and palliative care. In addition to her clinical responsibilities, Dr. Hosick serves on the Oncology Formulary Evaluation Team. Her research will evaluate an alternative dosing scheme of enfortumab in urothelial carcinoma. Upon completion of PGY2, she plans to pursue specialty board certification and stay in North Carolina as an oncology pharmacist where she can further pursue research, teaching, and precepting. Outside of pharmacy, she enjoys spending time with her boyfriend, dog, and rabbit, hiking, mountain biking, attending indie concerts, and watching reality TV.